Abstract
ISG15 (interferon-stimulated gene 15) is a novel ubiquitin-like (UbL) modifier with two UbL domains in its architecture. We investigated different roles for the two UbL domains in protein modification by ISG15 (ISGylation) and the impact of Influenza B virus NS1 protein (NS1B) on regulation of the pathway. The results show that, although the C-terminal domain is sufficient to link ISG15 to UBE1L and UbcH8, the N-terminal domain is dispensable in the activation and transthiolation steps but required for efficient E3-mediated transfer of ISG15 from UbcH8 to its substrates. NS1B specifically binds to the N-terminal domain of ISG15 but does not affect ISG15 linkage via a thioester bond to its activating and conjugating enzymes. However, it does inhibit the formation of cellular ISG15 conjugates upon interferon treatment. We propose that the N-terminal UbL domain of ISG15 mainly functions in the ligation step and NS1B inhibits ISGylation by competing with E3 ligases for binding to the N-terminal domain. © 2008 by The American Society for Biochemistry and Molecular Biology, Inc.
Cite
CITATION STYLE
Chang, Y. G., Yan, X. Z., Xie, Y. Y., Gao, X. C., Song, A. X., Zhang, D. E., & Hu, H. Y. (2008). Different roles for two ubiquitin-like domains of ISG15 in protein modification. Journal of Biological Chemistry, 283(19), 13370–13377. https://doi.org/10.1074/jbc.M800162200
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.